Home Capital Broker's Calls

Hyphens Pharma's growth mindset catches the eye of CGS-CIMB

Amala Balakrishner
Amala Balakrishner1/7/2022 3:4 PM GMT+08  • 2 min read
Hyphens Pharma's growth mindset catches the eye of CGS-CIMB
CGS-CIMB is initiating coverage on Hyphens Pharma with an ‘add’ call and target price of 36 cents.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

CGS-CIMB is initiating coverage on Hyphens Pharma with an ‘add’ call and target price of 36 cents.

This is expected to give the counter a 22% upside from its current 29.5 cent price, analyst Tay Wee Kuang writes in a Jan 6 report.

“We like Hyphens Pharma for its resilient business model and growing product portfolio as well as sales and distribution channels that will drive future earnings growth,” he notes.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.